Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Non-Current Liabilities: 2010-2024

Historic Other Non-Current Liabilities for Rockwell Medical (RMTI) over the last 8 years, with Dec 2024 value amounting to $1.0 million.

  • Rockwell Medical's Other Non-Current Liabilities rose 16.00% to $2.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.9 million, marking a year-over-year increase of 16.00%. This contributed to the annual value of $1.0 million for FY2024, which is 60.00% down from last year.
  • Rockwell Medical's Other Non-Current Liabilities amounted to $1.0 million in FY2024, which was down 60.00% from $2.5 million recorded in FY2023.
  • Rockwell Medical's Other Non-Current Liabilities' 5-year high stood at $2.5 million during FY2023, with a 5-year trough of $14,000 in FY2021.
  • Over the past 3 years, Rockwell Medical's median Other Non-Current Liabilities value was $1.0 million (recorded in 2024), while the average stood at $1.2 million.
  • As far as peak fluctuations go, Rockwell Medical's Other Non-Current Liabilities surged by 17,757.14% in 2023, and later crashed by 60.00% in 2024.
  • Rockwell Medical's Other Non-Current Liabilities (Yearly) stood at $14,000 in 2021, then remained steady at $14,000 in 2022, then skyrocketed by 17,757.14% to $2.5 million in 2023, then crashed by 60.00% to $1.0 million in 2024.